Endo Pharmaceuticals Inc. v. Actavis Inc.
1:12-cv-08985
Overview
Parties
Defendant
Actavis Inc. Operating Company
Represented By
5 Attorneys ListedHolland & Knight LLP (NY)
31 West 52nd Street, New York, NY 10019
Holland & Knight LLP (NY)
31 West 52nd Street, New York, NY 10019
Holland & Knight LLP (NY)
31 West 52nd Street, New York, NY 10019
Holland & Knight LLP (NY)
31 West 52nd Street, New York, NY 10019
Actavis South Atlantic LLC Operating Company
Represented By
5 Attorneys ListedHolland & Knight LLP (NY)
31 West 52nd Street, New York, NY 10019
Holland & Knight LLP (NY)
31 West 52nd Street, New York, NY 10019
Holland & Knight LLP (NY)
31 West 52nd Street, New York, NY 10019
Holland & Knight LLP (NY)
31 West 52nd Street, New York, NY 10019
Endo Pharmaceuticals Inc. Operating Company
Represented By
11 Attorneys ListedDechert LLP
902 Carnegie Center - Suite 500, Princeton, NJ 08540
Dechert LLP
Cira Centre 2929 Arch Street, US, PA 19104
Dechert, LLP (NYC)
1095 Avenue of the Americas, New York, NY 10036-6797
Dechert LLP (TX)
300 WEst 6th Street, Suite 2010, Austin, TX 78701
Dechert LLP (PHILADELPHIA)
Cira Centre 2929 Arch Street, Philadelphia, PA 19104
Dechert, LLP (NJ)
902 Carnegie Center, Princeton, NJ 08540
Dechert LLP
2440 W El Camino Real, Sutie 700, Mountain View, CA 94040
Dechert, LLP (NYC)
1095 Avenue of the Americas, New York, NY 10036-6797
Dechert LLP
2440 W. El Camino Real, Suite 700, Mountain View, CA 94040
Dechert, LLP (NJ)
902 Carnegie Center, Princeton, NJ 08540
Dechert LLP
Cira Centre, 2929 Arch Street, Philadelphia, PA 19104
Court & Judges
Court
District Court, S.D. New York (nysd)
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 8,309,122 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 30,335,701 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 32,943,201 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 32,944,501 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 32,944,401 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,820,982 B2 | US Continuation / Sibling | View Official Patent → |
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc.
Endo Pharmaceuticals Inc. v. Impax Laboratories, Inc.
Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC
Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8309122
Oxymorphone controlled release formulations
|
Filed: 2007-02-28
Issued: 2012-11-13
|
Expired (Term Ended)
Expires: 2026-03-08
|
|
|
US8329216
Oxymorphone controlled release formulations
|
Filed: 2006-06-29
Issued: 2012-12-11
|
Expired (Term Ended)
Expires: 2025-10-07
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
25
Dispositive
5
Granted
4
Denied
4
Pending / Review
17
Motions by Category
Key Dispositive Motions & Rulings